TidalSense is a privately held company tracked for investment-relevant business and technology developments.
This slot renders the company's funding history: dates, rounds, amounts, valuations and lead investors once populated in data/funding-rounds.json.
TidalSense has developed a handheld CO2-sensor device with machine learning interpretation that diagnoses COPD in under 4 minutes versus 1 hour for legacy spirometry, with NHS deployment showing overwhelming demand and plans for FDA clearance and China market entry.